Structure

Physi-Chem Properties

Molecular Weight:  500.13
Volume:  482.978
LogP:  2.025
LogD:  0.403
LogS:  -2.092
# Rotatable Bonds:  9
TPSA:  191.05
# H-Bond Aceptor:  11
# H-Bond Donor:  6
# Rings:  3
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.183
Synthetic Accessibility Score:  4.065
Fsp3:  0.24
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.307
MDCK Permeability:  1.6174570191651583e-05
Pgp-inhibitor:  0.0
Pgp-substrate:  0.957
Human Intestinal Absorption (HIA):  0.525
20% Bioavailability (F20%):  0.998
30% Bioavailability (F30%):  0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.055
Plasma Protein Binding (PPB):  98.13030242919922%
Volume Distribution (VD):  0.326
Pgp-substrate:  1.3848028182983398%

ADMET: Metabolism

CYP1A2-inhibitor:  0.151
CYP1A2-substrate:  0.021
CYP2C19-inhibitor:  0.135
CYP2C19-substrate:  0.047
CYP2C9-inhibitor:  0.618
CYP2C9-substrate:  0.896
CYP2D6-inhibitor:  0.029
CYP2D6-substrate:  0.161
CYP3A4-inhibitor:  0.478
CYP3A4-substrate:  0.052

ADMET: Excretion

Clearance (CL):  2.859
Half-life (T1/2):  0.943

ADMET: Toxicity

hERG Blockers:  0.051
Human Hepatotoxicity (H-HT):  0.142
Drug-inuced Liver Injury (DILI):  0.206
AMES Toxicity:  0.014
Rat Oral Acute Toxicity:  0.19
Maximum Recommended Daily Dose:  0.357
Skin Sensitization:  0.922
Carcinogencity:  0.183
Eye Corrosion:  0.003
Eye Irritation:  0.033
Respiratory Toxicity:  0.043

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC220664

Natural Product ID:  NPC220664
Common Name*:   1-O-Trans-Caffeoyl-5-O-Trans-P-Coumaroylquinic Acid
IUPAC Name:   (1S,3R,4R,5R)-1-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-3,4-dihydroxy-5-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxycyclohexane-1-carboxylic acid
Synonyms:  
Standard InCHIKey:  SZQUAPJIXVTPBU-ZQQDKFTKSA-N
Standard InCHI:  InChI=1S/C25H24O11/c26-16-6-1-14(2-7-16)4-9-21(30)35-20-13-25(24(33)34,12-19(29)23(20)32)36-22(31)10-5-15-3-8-17(27)18(28)11-15/h1-11,19-20,23,26-29,32H,12-13H2,(H,33,34)/b9-4+,10-5+/t19-,20-,23-,25+/m1/s1
SMILES:  c1cc(ccc1/C=C/C(=O)O[C@@H]1C[C@@](C[C@H]([C@H]1O)O)(C(=O)O)OC(=O)/C=C/c1ccc(c(c1)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2349421
PubChem CID:   71719612
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000129] Alcohols and polyols
          • [CHEMONTID:0001292] Cyclic alcohols and derivatives
            • [CHEMONTID:0002509] Cyclitols and derivatives
              • [CHEMONTID:0002512] Quinic acids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33307 pimpinella brachycarpa Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[23462643]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT34 Cell Line BV-2 Mus musculus Activity = 94.3 % PMID[452724]
NPT34 Cell Line BV-2 Mus musculus IC50 = 23530.0 nM PMID[452724]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC220664 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC284948
1.0 High Similarity NPC319628
1.0 High Similarity NPC303090
1.0 High Similarity NPC37331
0.9926 High Similarity NPC206095
0.9926 High Similarity NPC477335
0.9926 High Similarity NPC224389
0.9926 High Similarity NPC297517
0.9926 High Similarity NPC35702
0.9926 High Similarity NPC471027
0.9926 High Similarity NPC13818
0.9853 High Similarity NPC277315
0.9853 High Similarity NPC472016
0.9853 High Similarity NPC43158
0.9853 High Similarity NPC192831
0.9853 High Similarity NPC258469
0.9704 High Similarity NPC219428
0.9704 High Similarity NPC152942
0.9704 High Similarity NPC283560
0.9704 High Similarity NPC302857
0.9704 High Similarity NPC37250
0.9704 High Similarity NPC24295
0.9704 High Similarity NPC278068
0.9704 High Similarity NPC142703
0.9643 High Similarity NPC471076
0.9643 High Similarity NPC192568
0.9632 High Similarity NPC474875
0.9632 High Similarity NPC476820
0.9632 High Similarity NPC26241
0.9632 High Similarity NPC274891
0.9632 High Similarity NPC303683
0.9632 High Similarity NPC476819
0.9632 High Similarity NPC295492
0.9632 High Similarity NPC205751
0.9568 High Similarity NPC477333
0.9437 High Similarity NPC42464
0.9433 High Similarity NPC322660
0.9407 High Similarity NPC68517
0.9371 High Similarity NPC306343
0.9366 High Similarity NPC43123
0.9338 High Similarity NPC182217
0.9338 High Similarity NPC233350
0.9338 High Similarity NPC70680
0.9306 High Similarity NPC477334
0.9241 High Similarity NPC93498
0.9241 High Similarity NPC163883
0.9225 High Similarity NPC98356
0.9178 High Similarity NPC19380
0.9178 High Similarity NPC146277
0.9122 High Similarity NPC470896
0.9122 High Similarity NPC473275
0.9118 High Similarity NPC61
0.9118 High Similarity NPC25581
0.9118 High Similarity NPC18074
0.9118 High Similarity NPC5419
0.9085 High Similarity NPC50221
0.9085 High Similarity NPC114242
0.9071 High Similarity NPC179505
0.9071 High Similarity NPC156709
0.9054 High Similarity NPC145425
0.9051 High Similarity NPC168799
0.9051 High Similarity NPC155209
0.9044 High Similarity NPC198388
0.9041 High Similarity NPC252979
0.9028 High Similarity NPC229264
0.8951 High Similarity NPC226738
0.8951 High Similarity NPC22176
0.8951 High Similarity NPC190587
0.8951 High Similarity NPC121573
0.8929 High Similarity NPC279676
0.8929 High Similarity NPC67349
0.8873 High Similarity NPC38473
0.8867 High Similarity NPC134925
0.8849 High Similarity NPC474895
0.8836 High Similarity NPC142528
0.8811 High Similarity NPC477277
0.8811 High Similarity NPC477278
0.8792 High Similarity NPC44730
0.8741 High Similarity NPC477279
0.8714 High Similarity NPC106406
0.8707 High Similarity NPC120621
0.8707 High Similarity NPC248257
0.8696 High Similarity NPC217052
0.8696 High Similarity NPC329344
0.8696 High Similarity NPC237506
0.8696 High Similarity NPC32626
0.869 High Similarity NPC160378
0.8675 High Similarity NPC203757
0.8671 High Similarity NPC75763
0.8671 High Similarity NPC225036
0.8671 High Similarity NPC288452
0.8671 High Similarity NPC12218
0.8671 High Similarity NPC289690
0.8671 High Similarity NPC105525
0.8658 High Similarity NPC140151
0.8649 High Similarity NPC75945
0.8649 High Similarity NPC92117
0.8645 High Similarity NPC227297
0.8643 High Similarity NPC471749
0.8639 High Similarity NPC283081
0.8639 High Similarity NPC299090
0.8639 High Similarity NPC221383
0.8639 High Similarity NPC143892
0.8633 High Similarity NPC318799
0.8601 High Similarity NPC239943
0.86 High Similarity NPC246566
0.86 High Similarity NPC95498
0.8591 High Similarity NPC259576
0.8591 High Similarity NPC221091
0.8591 High Similarity NPC32197
0.8581 High Similarity NPC472969
0.8571 High Similarity NPC473867
0.8562 High Similarity NPC474692
0.8543 High Similarity NPC16024
0.8543 High Similarity NPC61152
0.8543 High Similarity NPC205037
0.8543 High Similarity NPC3746
0.8543 High Similarity NPC44260
0.854 High Similarity NPC475695
0.8535 High Similarity NPC471823
0.8533 High Similarity NPC300329
0.8531 High Similarity NPC84789
0.8531 High Similarity NPC302583
0.8531 High Similarity NPC100558
0.8531 High Similarity NPC310252
0.8523 High Similarity NPC476394
0.8523 High Similarity NPC98809
0.8503 High Similarity NPC53884
0.8503 High Similarity NPC258671
0.85 High Similarity NPC108553
0.8489 Intermediate Similarity NPC94810
0.8483 Intermediate Similarity NPC9218
0.8481 Intermediate Similarity NPC128403
0.8477 Intermediate Similarity NPC75695
0.8477 Intermediate Similarity NPC106818
0.8456 Intermediate Similarity NPC98009
0.8451 Intermediate Similarity NPC34293
0.8451 Intermediate Similarity NPC886
0.8451 Intermediate Similarity NPC248150
0.8451 Intermediate Similarity NPC287597
0.8435 Intermediate Similarity NPC304956
0.8435 Intermediate Similarity NPC229036
0.8435 Intermediate Similarity NPC470130
0.8421 Intermediate Similarity NPC475216
0.8421 Intermediate Similarity NPC87403
0.8421 Intermediate Similarity NPC475595
0.8421 Intermediate Similarity NPC475162
0.8421 Intermediate Similarity NPC83663
0.8421 Intermediate Similarity NPC266084
0.8421 Intermediate Similarity NPC475145
0.8421 Intermediate Similarity NPC473544
0.8411 Intermediate Similarity NPC243891
0.8406 Intermediate Similarity NPC168653
0.8406 Intermediate Similarity NPC251407
0.8394 Intermediate Similarity NPC85565
0.8392 Intermediate Similarity NPC123988
0.8392 Intermediate Similarity NPC18646
0.8387 Intermediate Similarity NPC471750
0.8387 Intermediate Similarity NPC74319
0.8387 Intermediate Similarity NPC287872
0.8378 Intermediate Similarity NPC108455
0.8377 Intermediate Similarity NPC247629
0.8377 Intermediate Similarity NPC239019
0.8366 Intermediate Similarity NPC477299
0.8366 Intermediate Similarity NPC125487
0.8366 Intermediate Similarity NPC191046
0.8366 Intermediate Similarity NPC194095
0.8366 Intermediate Similarity NPC327032
0.8366 Intermediate Similarity NPC281703
0.8357 Intermediate Similarity NPC226855
0.8355 Intermediate Similarity NPC476434
0.8355 Intermediate Similarity NPC267091
0.8345 Intermediate Similarity NPC328273
0.8345 Intermediate Similarity NPC321184
0.8345 Intermediate Similarity NPC321638
0.8345 Intermediate Similarity NPC171134
0.8345 Intermediate Similarity NPC284409
0.8344 Intermediate Similarity NPC473091
0.8344 Intermediate Similarity NPC4013
0.8344 Intermediate Similarity NPC144557
0.8344 Intermediate Similarity NPC90905
0.8333 Intermediate Similarity NPC156892
0.8333 Intermediate Similarity NPC289346
0.8333 Intermediate Similarity NPC301089
0.8333 Intermediate Similarity NPC24164
0.8333 Intermediate Similarity NPC28776
0.8333 Intermediate Similarity NPC473138
0.8333 Intermediate Similarity NPC44507
0.8333 Intermediate Similarity NPC132921
0.8323 Intermediate Similarity NPC156818
0.8323 Intermediate Similarity NPC226759
0.8323 Intermediate Similarity NPC40920
0.8323 Intermediate Similarity NPC472860
0.8323 Intermediate Similarity NPC38779
0.8323 Intermediate Similarity NPC133984
0.8323 Intermediate Similarity NPC68324
0.8323 Intermediate Similarity NPC223335
0.8323 Intermediate Similarity NPC160512
0.8323 Intermediate Similarity NPC114179
0.8323 Intermediate Similarity NPC289322

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC220664 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
1.0 High Similarity NPD6190 Approved
0.8258 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8252 Intermediate Similarity NPD230 Phase 1
0.8219 Intermediate Similarity NPD7266 Discontinued
0.8 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7964 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD3817 Phase 2
0.7799 Intermediate Similarity NPD3882 Suspended
0.7791 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD6166 Phase 2
0.7791 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.774 Intermediate Similarity NPD6233 Phase 2
0.7736 Intermediate Similarity NPD5402 Approved
0.773 Intermediate Similarity NPD9269 Phase 2
0.7725 Intermediate Similarity NPD7685 Pre-registration
0.7697 Intermediate Similarity NPD3818 Discontinued
0.7673 Intermediate Similarity NPD2801 Approved
0.7665 Intermediate Similarity NPD6797 Phase 2
0.7662 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD7075 Discontinued
0.7619 Intermediate Similarity NPD7251 Discontinued
0.761 Intermediate Similarity NPD1934 Approved
0.7593 Intermediate Similarity NPD6234 Discontinued
0.759 Intermediate Similarity NPD3751 Discontinued
0.7582 Intermediate Similarity NPD4628 Phase 3
0.7582 Intermediate Similarity NPD8166 Discontinued
0.758 Intermediate Similarity NPD1653 Approved
0.7564 Intermediate Similarity NPD1512 Approved
0.7562 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7551 Intermediate Similarity NPD3764 Approved
0.7545 Intermediate Similarity NPD5844 Phase 1
0.75 Intermediate Similarity NPD9545 Approved
0.75 Intermediate Similarity NPD6801 Discontinued
0.75 Intermediate Similarity NPD37 Approved
0.7484 Intermediate Similarity NPD4380 Phase 2
0.7483 Intermediate Similarity NPD3027 Phase 3
0.7471 Intermediate Similarity NPD7808 Phase 3
0.7469 Intermediate Similarity NPD4965 Approved
0.7469 Intermediate Similarity NPD4967 Phase 2
0.7469 Intermediate Similarity NPD4966 Approved
0.7455 Intermediate Similarity NPD6232 Discontinued
0.7455 Intermediate Similarity NPD3787 Discontinued
0.7453 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7453 Intermediate Similarity NPD1465 Phase 2
0.745 Intermediate Similarity NPD943 Approved
0.7447 Intermediate Similarity NPD9268 Approved
0.744 Intermediate Similarity NPD7054 Approved
0.7436 Intermediate Similarity NPD1511 Approved
0.7436 Intermediate Similarity NPD6799 Approved
0.7432 Intermediate Similarity NPD6798 Discontinued
0.7431 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7429 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7405 Intermediate Similarity NPD5403 Approved
0.7399 Intermediate Similarity NPD8150 Discontinued
0.7396 Intermediate Similarity NPD7472 Approved
0.7396 Intermediate Similarity NPD7074 Phase 3
0.7381 Intermediate Similarity NPD7228 Approved
0.7347 Intermediate Similarity NPD9494 Approved
0.7333 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD1613 Approved
0.7321 Intermediate Similarity NPD7473 Discontinued
0.7317 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD3455 Phase 2
0.7289 Intermediate Similarity NPD7199 Phase 2
0.7278 Intermediate Similarity NPD5401 Approved
0.7255 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD7095 Approved
0.7216 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD8434 Phase 2
0.7179 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD6355 Discontinued
0.716 Intermediate Similarity NPD6599 Discontinued
0.7152 Intermediate Similarity NPD4062 Phase 3
0.7135 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD6385 Approved
0.7117 Intermediate Similarity NPD6386 Approved
0.7105 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD2935 Discontinued
0.7083 Intermediate Similarity NPD8127 Discontinued
0.7067 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD4340 Discontinued
0.7032 Intermediate Similarity NPD1510 Phase 2
0.7032 Intermediate Similarity NPD7033 Discontinued
0.703 Intermediate Similarity NPD7819 Suspended
0.7027 Intermediate Similarity NPD7435 Discontinued
0.7024 Intermediate Similarity NPD5494 Approved
0.7012 Intermediate Similarity NPD7411 Suspended
0.7006 Intermediate Similarity NPD1549 Phase 2
0.7 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.6993 Remote Similarity NPD4060 Phase 1
0.6988 Remote Similarity NPD5353 Approved
0.6987 Remote Similarity NPD9570 Approved
0.6961 Remote Similarity NPD6535 Approved
0.6961 Remote Similarity NPD6534 Approved
0.6957 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6957 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6948 Remote Similarity NPD447 Suspended
0.6944 Remote Similarity NPD5536 Phase 2
0.6943 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6943 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6928 Remote Similarity NPD8455 Phase 2
0.6918 Remote Similarity NPD3750 Approved
0.6914 Remote Similarity NPD7038 Approved
0.6914 Remote Similarity NPD6559 Discontinued
0.6914 Remote Similarity NPD7039 Approved
0.6914 Remote Similarity NPD7240 Approved
0.6901 Remote Similarity NPD5242 Approved
0.6899 Remote Similarity NPD970 Clinical (unspecified phase)
0.6898 Remote Similarity NPD8320 Phase 1
0.6898 Remote Similarity NPD8319 Approved
0.6892 Remote Similarity NPD1608 Approved
0.6883 Remote Similarity NPD825 Approved
0.6883 Remote Similarity NPD826 Approved
0.6879 Remote Similarity NPD1551 Phase 2
0.6875 Remote Similarity NPD3887 Approved
0.6875 Remote Similarity NPD2354 Approved
0.6865 Remote Similarity NPD6782 Approved
0.6865 Remote Similarity NPD6780 Approved
0.6865 Remote Similarity NPD6778 Approved
0.6865 Remote Similarity NPD6777 Approved
0.6865 Remote Similarity NPD6781 Approved
0.6865 Remote Similarity NPD6779 Approved
0.6865 Remote Similarity NPD6776 Approved
0.6864 Remote Similarity NPD919 Approved
0.6857 Remote Similarity NPD3021 Approved
0.6857 Remote Similarity NPD3022 Approved
0.6853 Remote Similarity NPD2629 Approved
0.6852 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6852 Remote Similarity NPD3146 Approved
0.6852 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6848 Remote Similarity NPD7699 Phase 2
0.6848 Remote Similarity NPD7700 Phase 2
0.6836 Remote Similarity NPD8312 Approved
0.6836 Remote Similarity NPD8313 Approved
0.6824 Remote Similarity NPD1535 Discovery
0.6818 Remote Similarity NPD6663 Approved
0.6813 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6813 Remote Similarity NPD4110 Phase 3
0.6813 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6806 Remote Similarity NPD7874 Approved
0.6806 Remote Similarity NPD4198 Discontinued
0.6806 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6805 Remote Similarity NPD3749 Approved
0.68 Remote Similarity NPD3225 Approved
0.6792 Remote Similarity NPD4534 Discontinued
0.6792 Remote Similarity NPD5958 Discontinued
0.679 Remote Similarity NPD4357 Discontinued
0.6788 Remote Similarity NPD3226 Approved
0.6786 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6784 Remote Similarity NPD1247 Approved
0.6779 Remote Similarity NPD1481 Phase 2
0.6776 Remote Similarity NPD5736 Approved
0.6774 Remote Similarity NPD1240 Approved
0.6772 Remote Similarity NPD5408 Approved
0.6772 Remote Similarity NPD5406 Approved
0.6772 Remote Similarity NPD2796 Approved
0.6772 Remote Similarity NPD5404 Approved
0.6772 Remote Similarity NPD5405 Approved
0.6763 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6752 Remote Similarity NPD7097 Phase 1
0.6748 Remote Similarity NPD2532 Approved
0.6748 Remote Similarity NPD2534 Approved
0.6748 Remote Similarity NPD2533 Approved
0.6746 Remote Similarity NPD7768 Phase 2
0.6738 Remote Similarity NPD2067 Discontinued
0.6731 Remote Similarity NPD555 Phase 2
0.673 Remote Similarity NPD2029 Clinical (unspecified phase)
0.6728 Remote Similarity NPD7236 Approved
0.6723 Remote Similarity NPD8368 Discontinued
0.6709 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6708 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6707 Remote Similarity NPD6273 Approved
0.6705 Remote Similarity NPD3926 Phase 2
0.6704 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6703 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6689 Remote Similarity NPD17 Approved
0.6688 Remote Similarity NPD6653 Approved
0.6688 Remote Similarity NPD1607 Approved
0.6687 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6687 Remote Similarity NPD7458 Discontinued
0.6686 Remote Similarity NPD6959 Discontinued
0.6667 Remote Similarity NPD7697 Approved
0.6667 Remote Similarity NPD1894 Discontinued
0.6667 Remote Similarity NPD7696 Phase 3
0.6667 Remote Similarity NPD2438 Suspended
0.6667 Remote Similarity NPD7698 Approved
0.6667 Remote Similarity NPD2861 Phase 2
0.6667 Remote Similarity NPD1501 Clinical (unspecified phase)
0.6649 Remote Similarity NPD3450 Approved
0.6649 Remote Similarity NPD3452 Approved
0.6649 Remote Similarity NPD2493 Approved
0.6649 Remote Similarity NPD2494 Approved
0.6648 Remote Similarity NPD8361 Approved
0.6648 Remote Similarity NPD8435 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data